Ep58. Part 1: Will the Burgeoning Bioeconomy be a force for Order or for Disorder?

Disorder - A podcast by Goalhanger & Global Enduring Disorder Ltd

Advanced biotech (CRISPR gene editing, gene drives, personalized medicine) could be the most Disordering technology ever invented. Techniques like gene drives could help us eradicate malaria by sterilising mosquitoes, but could they also spell the end of humanity (by unleashing unintended consequences)? Or release a new pandemic – think COVID-19 which was likely caused by a lab lead of a manmade super virus – into the population?    While biotech offers the potential to revolutionise everything, no one has yet proposed any coherent regulations over this domain. Seeking to learn more about advances in Biotech and how they interact with AI, globalization, and climate change we are joined by Jamie Metzl. Jamie is the author of Superconvergence, and Founder and Chair of the global social movement, OneShared.World. He and Jason discuss the vast opportunities and profound threats that emanate from biotech. Jason puts forth a more socially conservative vision that we need to learn from our collective past, what Jason calls the ‘French-peasant’ approach, while Jaime poopoos that approach advancing more boldly futuristic solutions.    To Order the Disorder, Jason and Alex discuss whether top-down or bottom-up governance solutions could help solve this issue, and what we need to do to regain the public’s trust in experts.    Twitter: @DisorderShow    Subscribe to our Substack: https://natoandtheged.substack.com/       Producer: George McDonagh  Exec Producer: Neil Fearn    Show Notes Links  Mega-order Jamie’s book, Superconvergence, at https://superconvergencebook.com/   For more on Jamie’s unbelievable career: https://jamiemetzl.com/   And his novel ‘Eternal Sonata’: https://www.goodreads.com/book/show/28695898-eternal-sonata   And his theories and extensive public engagement about the origins of COVID-19: https://jamiemetzl.com/origins-of-sars-cov-2/   Learn more about your ad choices. Visit podcastchoices.com/adchoices